Follow the links to download bioSyntagma’s poster presentation at AACR 2019!
Single biomarkers are no longer sufficient to describe complex biological systems such as the tumor microenvironmentor to predict response to targeted therapies. Advances in molecular analysis have led to the understanding that tumor growth is driven by a network of factors and that spatially resolved, multi-omic measurements are the key to understanding this complex network…
Phoenix, Arizona: bioSyntagma has been named a finalist for the competitive Katerva Awards,which recognize disruptive innovations in global sustainability. This comes after bioSyntagma’s recent debut of their mPrint Mind™, an artificial intelligence for screening cancer patients. “We are delighted by the new sand encouraged that such an innovative group recognizes the value of creating a sustainable healthcare system,” said David Richardson, CEO of bioSyntagma. Katerva scours the globe to identify the most promising, high-impact innovations
bioSyntagma has been awarded “Best Oncology-Focused Precision Medicine Company 2018” by Global Health and Pharma, a UK-based publication that recognizes global companies for improving public health, enhancing patient care, and lowering healthcare costs. This award follows several commercial milestones with strategic partners and Big Pharma using bioSyntagma’s beta-instruments to offer biomarker discovery services. Striving to eliminate-trial-and-error cancer treatments through predictive analytics and novel diagnostic tools, bioSyntagma has developed a suite of AI-enabled technologies that collectively create
Phoenix, AZ (October 30, 2018) – The Arizona Commerce Authority (ACA) today announced 25 semifinalists in the Fall 2018 round of the Arizona Innovation Challenge, a bi-annual business plan competition for promising early-stage companies in high-growth industries. As many as ten recipients in each round will receive up to $150,000 each in capital to grow their businesses, advancing innovation and technology commercialization opportunities in Arizona. The funding for each awardee will be released in phases,